N‐3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis. (15th March 2014)
- Record Type:
- Journal Article
- Title:
- N‐3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis. (15th March 2014)
- Main Title:
- N‐3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis
- Authors:
- Provenzano, Angela
Milani, Stefano
Vizzutti, Francesco
Delogu, Wanda
Navari, Nadia
Novo, Erica
Maggiora, Marina
Maurino, Valter
Laffi, Giacomo
Parola, Maurizio
Marra, Fabio - Abstract:
- <abstract abstract-type="main" id="liv12500-abs-0001"> <title>Abstract</title> <sec id="liv12500-sec-0001" sec-type="section"> <title>Background &amp; Aims</title> <p>n‐3 polyunsaturated fatty acids (PUFA) ameliorate fatty liver in experimental models, but their effects on inflammation and fibrosis during steatohepatitis are either controversial or lacking. We compared the effects of supplementation with olive oil (OO) alone or OO and n‐3 PUFA on the development and progression of experimental steatohepatitis.</p> </sec> <sec id="liv12500-sec-0002" sec-type="section"> <title>Methods</title> <p>Balb/C mice (≥5 mice/group) were fed a methionine‐ and choline‐deficient (MCD) diet or a control diet for 4 or 8 weeks. At the same time, mice were supplemented with n‐3 PUFA (eicosapentaenoic and docosahexahenoic acid, 25 mg together with 75 mg OO), or OO alone (100 mg), two times a week by intragastric gavage.</p> </sec> <sec id="liv12500-sec-0003" sec-type="section"> <title>Results</title> <p>After 8 weeks, mice on MCD/n‐3 had higher ALT levels compared to MCD/OO and more severe scores of inflammation, including a significant increase in the number of lipogranulomas (26.4 ± 8.4 vs. 5.1 ± 5 per field, <italic>P</italic> &lt; 0.001). Intrahepatic expression of TNF‐α and CCL2 was higher in MCD/n‐3 mice at both time points. In addition, increased expression of the profibrogenic genes TIMP‐1 and TGF‐β, and more severe histological scores of fibrosis were evident in MCD/n‐3 mice. After<abstract abstract-type="main" id="liv12500-abs-0001"> <title>Abstract</title> <sec id="liv12500-sec-0001" sec-type="section"> <title>Background &amp; Aims</title> <p>n‐3 polyunsaturated fatty acids (PUFA) ameliorate fatty liver in experimental models, but their effects on inflammation and fibrosis during steatohepatitis are either controversial or lacking. We compared the effects of supplementation with olive oil (OO) alone or OO and n‐3 PUFA on the development and progression of experimental steatohepatitis.</p> </sec> <sec id="liv12500-sec-0002" sec-type="section"> <title>Methods</title> <p>Balb/C mice (≥5 mice/group) were fed a methionine‐ and choline‐deficient (MCD) diet or a control diet for 4 or 8 weeks. At the same time, mice were supplemented with n‐3 PUFA (eicosapentaenoic and docosahexahenoic acid, 25 mg together with 75 mg OO), or OO alone (100 mg), two times a week by intragastric gavage.</p> </sec> <sec id="liv12500-sec-0003" sec-type="section"> <title>Results</title> <p>After 8 weeks, mice on MCD/n‐3 had higher ALT levels compared to MCD/OO and more severe scores of inflammation, including a significant increase in the number of lipogranulomas (26.4 ± 8.4 vs. 5.1 ± 5 per field, <italic>P</italic> &lt; 0.001). Intrahepatic expression of TNF‐α and CCL2 was higher in MCD/n‐3 mice at both time points. In addition, increased expression of the profibrogenic genes TIMP‐1 and TGF‐β, and more severe histological scores of fibrosis were evident in MCD/n‐3 mice. After 8 week of MCD diet, portal pressure was higher in mice receiving n‐3 than in those on OO alone (5.1 ± 1.4 vs. 7.0 ± 0.9 mmHg, <italic>P</italic> &lt; 0.05). Analysis of hepatic fatty acid profile showed that supplementation resulted in effective incorporation of n‐3 PUFA.</p> </sec> <sec id="liv12500-sec-0004" sec-type="section"> <title>Conclusions</title> <p>In a murine model of steatohepatitis, supplementation with n‐3 PUFA and OO is associated with more severe necro‐inflammation and fibrosis than in mice treated with OO only.</p> </sec> </abstract> … (more)
- Is Part Of:
- Liver international. Volume 34:Number 6(2014:Aug.)
- Journal:
- Liver international
- Issue:
- Volume 34:Number 6(2014:Aug.)
- Issue Display:
- Volume 34, Issue 6 (2014)
- Year:
- 2014
- Volume:
- 34
- Issue:
- 6
- Issue Sort Value:
- 2014-0034-0006-0000
- Page Start:
- 918
- Page End:
- 930
- Publication Date:
- 2014-03-15
- Subjects:
- Liver -- Periodicals
Liver -- Diseases -- Periodicals
616.362 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1478-3231 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/liv.12500 ↗
- Languages:
- English
- ISSNs:
- 1478-3223
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5280.514000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4116.xml